Abbott India

48
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
27,800.00
245 (0.89%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 6.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 8.11% vs 9.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.65% vs 16.62% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 118.64% vs -8.19% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 9.73% vs 17.75% in Mar 2025

Compare Profit and Loss Results of Abbott India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,929.00
9,226.00
-2,297.00
-24.90%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,929.00
9,226.00
-2,297.00
-24.90%
Expenditure (Ex Depriciation)
Stock Adjustments
-85.00
44.00
-129.00
-293.18%
Raw Materials Consumed
3,778.00
3,154.00
624.00
19.78%
Power & Fuel Cost
14.00
114.00
-100.00
-87.72%
Employee Cost
668.00
1,603.00
-935.00
-58.33%
Operating Expenses
145.00
254.00
-109.00
-42.91%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
159.00
956.00
-797.00
-83.37%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
66.00
387.00
-321.00
-82.95%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,036.00
6,982.00
-1,946.00
-27.87%
Operating Profit (PBDIT) excl Other Income
1,892.00
2,244.00
-352.00
-15.69%
Other Income
288.00
356.00
-68.00
-19.10%
Operating Profit (PBDIT)
2,180.00
2,600.00
-420.00
-16.15%
Interest
24.00
48.00
-24.00
-50.00%
Profit before Depriciation and Tax
2,155.00
2,551.00
-396.00
-15.52%
Depreciation
75.00
218.00
-143.00
-65.60%
Profit Before Taxation & Exceptional Items
2,079.00
2,333.00
-254.00
-10.89%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,079.00
2,154.00
-75.00
-3.48%
Provision for Tax
527.00
543.00
-16.00
-2.95%
Profit After Tax
1,552.00
1,610.00
-58.00
-3.60%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,220.00
21,088.00
-17,868.00
-84.73%
Profit Available for appropriations
4,772.00
22,698.00
-17,926.00
-78.98%
Appropriations
4,772.00
22,698.00
-17,926.00
-78.98%
Equity Dividend (%)
6560%
250%
6,310.00
Earnings Per Share
730.36
57.07
673.29
1,179.76%
Profit And Loss - Net Sales
Net Sales 6,929.05 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.11% vs 9.58% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,892.08 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.65% vs 16.62% in Mar 2025

Profit And Loss - Interest
Interest 24.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 118.64% vs -8.19% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1,552.02 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.73% vs 17.75% in Mar 2025